BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
99 results:

  • 1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.
    Tantawy MN; McIntyre JO; Yull F; Calcutt MW; Koktysh DS; Wilson AJ; Zu Z; Nyman J; Rhoades J; Peterson TE; Colvin D; McCawley LJ; Rook JM; Fingleton B; Crispens MA; Alvarez RD; Gore JC
    Cancer Med; 2024 Feb; 13(3):e6812. PubMed ID: 38239047
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metastatic Lymph Node 64 (MLN64) Expression in Gastric cancer: The Clinical and Molecular Implications in Drug Resistance.
    Li AX; Zeng JJ; Khan E; Dou QP; Zhuang X; Ji EK; Ruge F; Martin TA; Jia S; Jiang WG
    Cancer Genomics Proteomics; 2024; 21(1):30-40. PubMed ID: 38151289
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive cancers: Breast cancer, Cervical cancer, Endometrial cancer, Ovarian cancer and prostate cancer.
    Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy.
    Best O; Canagasingham A; Liu Z; Doan P; Haynes AM; Delprado W; Maclean F; Yuen C; Stricker P; Thompson J
    Pathology; 2023 Jun; 55(4):492-497. PubMed ID: 36725447
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Androgen Receptor as an Emerging Feasible Biomarker for Breast cancer.
    You CP; Leung MH; Tsang WC; Khoo US; Tsoi H
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053220
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast cancer.
    Ye H; Zhang N
    Comput Math Methods Med; 2021; 2021():1498924. PubMed ID: 34868337
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.
    Ye T; Li J; Feng J; Guo J; Wan X; Xie D; Liu J
    J Cell Mol Med; 2021 Aug; 25(15):7307-7320. PubMed ID: 34191390
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review.
    Jahan N; Jones C; Rahman RL
    Mol Cell Endocrinol; 2021 Jul; 531():111324. PubMed ID: 34000352
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Template-Assisted Plasmonic Nanogap Shells for Highly Enhanced Detection of cancer Biomarkers.
    Kang H; Jeong S; Yang JK; Jo A; Lee H; Heo EH; Jeong DH; Jun BH; Chang H; Lee YS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578653
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CDK12 and her2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression.
    Yanai Y; Kosaka T; Nakamura K; Aimono E; Matsumoto K; Morita S; Mikami S; Nishihara H; Oya M
    Cancer Sci; 2020 Dec; 111(12):4652-4655. PubMed ID: 33038052
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Alpha-Particle Therapy for Multifocal Osteosarcoma: A Hypothesis.
    Baranowska-Kortylewicz J; Sharp JG; McGuire TR; Joshi S; Coulter DW
    Cancer Biother Radiopharm; 2020 Aug; 35(6):418-424. PubMed ID: 32073902
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast cancer Patients.
    Krishna Latha T; Verma A; Thakur GK; Banerjee B; Kaur N; Singh UR; Sharma S
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3321-3329. PubMed ID: 31759355
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists.
    Muñoz-Moreno L; Carmena MJ; Schally AV; Prieto JC; Bajo AM
    Invest New Drugs; 2020 Jun; 38(3):746-754. PubMed ID: 31312936
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States.
    Shabihkhani M; Patil P; Murati Amador B; Plaza JA; Osunkoya AO; Lombardo KA; Epstein JI; Matoso A
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):524-531. PubMed ID: 31290785
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
    Hammarsten P; Josefsson A; Thysell E; Lundholm M; Hägglöf C; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Granfors T; Wikström P; Bergh A
    Mod Pathol; 2019 Sep; 32(9):1310-1319. PubMed ID: 30980038
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in cancer Tissue Using Forkhead Box-O Target Gene Expression in a Knowledge-Based Computational Model.
    van Ooijen H; Hornsveld M; Dam-de Veen C; Velter R; Dou M; Verhaegh W; Burgering B; van de Stolpe A
    Am J Pathol; 2018 Sep; 188(9):1956-1972. PubMed ID: 30030980
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.
    Ferreira C; Lobo J; Antunes L; Lopes P; Jerónimo C; Henrique R
    Virchows Arch; 2018 Oct; 473(4):443-452. PubMed ID: 30006753
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer.
    Li C; Cao L; Xu C; Liu F; Xiang G; Liu X; Jiao J; Niu Y
    Hum Pathol; 2018 May; 75():16-25. PubMed ID: 29180246
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.